Comparison of rivaroxaban-based dual antithrombotic and antiplatelet therapies for symptomatic patients with lower-extremity peripheral artery disease post-revascularization: a retrospective cohort study.

Ther Adv Chronic Dis · 2023 · PMC10699158 · PMID 38085917

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

In the RAPT group, a nonsignificant trend was observed for an increased risk of major bleeding as per the ISTH criteria (HR: 2.33, 95% CI: 0.88–6.20).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.